All Type of News
LG Life Science to develop vaccines for bovine mastitis
LG Life Science has succeeded in developing a vaccine for the bovine mastitis through a gene recombinant technology first in Korea.
LG Life Science developed the bovine mastitis vaccine for the milk cows by using a...
Daewoong's Q1 sales grew up with Gasmotin and Nicostop.
Daewoong reported 80,238 million won of sales during the Q1 of 2005 (April to June 2005), which was nearly 10 billion won of increase over the same period of last year, 9,784 MW of operating income, 8,784 MW of ordina...
840 town clinics newly registered last year.
As of Dec. 2004 the total number of medical institutions was 47,403 having 356,778 beds, which showed increases of 2,006 institutions including 840 more town clinics and 26,000 bed from the previous year.
The MOHW'...
MOHW selected 80 hospitals for review
80 hospitals including Choongang Univ. hospital and St. Mary Benevolence Hospital have been nominated by the MOHW for the medical institution to review in 2005, which starts its field inspection from Oct. 4 to Nov. 18...
CJ to export rhG-CSF to UK GeneMedix.
CJ pharmaceutical division announced on Aug. 9 for Leucocain (rhG-CSF), a recombinant granulocyte colonial stimulating factor, to export to GeneMedix in England.
An insider of CJ Pharm. division said that the expor...
70% of new drug R&D targeted on natural, bio and modified drugs.
The new drug R&D in Korea targeted to the synthetic chemical compounds by 35%, the natural crude drug by 22%, the modified new drug by 14% and the bio tech product by 29%, showing more weight shift from the synthetic ...
Kuhnil to acquire exclusive license for a super antibiotic.
Kuhnil made an exclusive distribution agreement for Cubicin, a super antibiotic, even sensitive to MRSA (methicillin-resistant Staphylococcus aureus), with Cubist Inc., located in Boston, U.S.A on July 14.
Cubist I...
Daewoong to decide wholesale policies after 3 month test.
Daewoong indicated that their new wholesale policies controversial by the wholesaler's group seem to be finalized after the 3 months market test, according to the Seoul Pharmaceutical Association (SPA).
When the SP...
Drug industries to solidify their identities via brand changes.
The pharmaceutical industry showed an active movement of changing their company names for the purpose of establishing their identities and leap-up targeting the new bio drugs and its science for their business growing...
Dongwha to register patent for a Quinolone derivative.
Dongwha announced on Aug. 9 that the company completed a patent registration under the No. 0497942 for an optically active form of 7-pyrrolidine quinolin carboxylic acid derivative and its production process in Korea....
